IL-13
Term · Oncology and biomedicine · MLC-T-ONC-004155
One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. IL-13 is made by a type of T lymphocyte. It reduces inflammation by blocking production of cytokines by macrophages. It also increases the number and activity of B lymphocytes. IL-13 made in the laboratory is used as a biological response modifier to boost the immune system in cancer therapy. It is a type of cytokine. Also called interleukin-13.
| Identifier | MLC-T-ONC-004155 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | interleukin-13 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004155",
"term": "IL-13",
"field": "Oncology and biomedicine",
"definition": "One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. IL-13 is made by a type of T lymphocyte. It reduces inflammation by blocking production of cytokines by macrophages. It also increases the number and activity of B lymphocytes. IL-13 made in the laboratory is used as a biological response modifier to boost the immune system in cancer therapy. It is a type of cytokine. Also called interleukin-13.",
"expansions": [
"interleukin-13"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/il-13/"
}
Record 8,995 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.